Related Experiment Video
Updated: May 26, 2026

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
Material-driven glucose responsiveness in insulin delivery systems: carrier selection and performance
Zhihan Li1, Jingge Jiang1, Ziyu Zhu2
1Department of Pharmacy, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Abstract:
Conventional subcutaneous insulin therapy faces limitations in patient adherence and carries a persistent risk of hypoglycemia, primarily due to the challenges of achieving precise dosing. To address this, glucose-responsive insulin delivery systems have been developed to autonomously adjust insulin release in direct response to real-time fluctuations in blood glucose levels. This approach offers a promising pathway toward achieving more physiological glycemic control. This review systematically summarizes recent advances in the design of such intelligent systems, with a focus on two fundamentally interconnected components: the ongoing evolution of glucose-sensing mechanisms, which encompass enzymatic, non-enzymatic, and transporter-mediated strategies, and the parallel development of advanced carrier materials, including metal-organic frameworks, smart polymers, and bio-derived materials. In addition to outlining these technological developments, this work provides a balanced analysis of the operational principles, relative merits, and key translational challenges inherent in current system designs, with particular attention to long-term biocompatibility, stability, and safety. By presenting a coherent synthesis of the field's current landscape and its potential future directions, this review aims to inform and support the rational development of next-generation glucose-responsive insulin therapies with stronger prospects for clinical translation.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Oral Hypoglycemic Agents: Glinides
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Membrane Proteins
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

